	Clinician perspectives on OFF periods in Parkinson's disease: the Spanish PARK-OFF survey-based study. Front Neurol Ruiz-Martínez J, Rezola EM, Aragón AV, Vilella LP, Marcos MSC, Caballero DC, PARK-OFF Study group. PMID: 42806998 [PubMed - indexed for MEDLINE]
	Î±-Synuclein Seeding Discriminates Between LRRK2 G2019S Variant Carriers with and Without Parkinson's Disease. Mov Disord Lüth T, Gabbert C, Kleinz T, Much C, Laabs BH, Sendel S, König IR, Caliebe A, Farrer M, Fiske B, Blauwendraat C, Klein C, Trinh J, Global Parkinson's Genetics Program (GP2). PMID: 42806694 [PubMed - as supplied by publisher]
	Improving Video-Based Prediction of Cerebellar Ataxia Severity Using a Pretrained Deep Learning Model. Brain Behav Eguchi K, Yaguchi H, Uwatoko H, Iida Y, Yamada M, Hamada S, Sato K, Honma S, Takei A, Kawashima A, Moriwaka F, Fukazawa T, Togo R, Ogawa T, Haseyama M, Hirata K, Kudo K, Tanaka S, Yabe I. PMID: 42806624 [PubMed - indexed for MEDLINE]
	Continuous infusion therapy after deep brain stimulation in Parkinson's disease: indications, outcomes, and patient selection. J Neural Transm (Vienna) Hero M, Papi, Grozdani, Vuleti. PMID: 42806146 [PubMed - as supplied by publisher]
	Oral Environment and Aspiration Pneumonia Risk in Parkinson's Disease: A Narrative Review and Conceptual Framework. J Oral Rehabil Furuya H, Longnecker D, Almazan E, Hinojosa O, Rochester T, Carnaby G. PMID: 42805786 [PubMed - as supplied by publisher]
	Advances in the management of depression in Parkinson's disease: A narrative review on vortioxetine, hyperbaric oxygen, and physical activity. Biomed Pharmacother Mesquita I, Araújo B, Soares-Guedes C, Teixeira C, Caridade-Silva R, Summavielle T, Pinto L, Domingos J, Godinho C, Teixeira FG. PMID: 42805007 [PubMed - as supplied by publisher]
	Explicit Mechanistic Causal Analyses or Interventional Trials Are Required for Objective, Clinical, Voice-Based Parkinson Disease Characterization. J Med Internet Res Little M. PMID: 42804162 [PubMed - indexed for MEDLINE]
	Interlocking pentagons task and visuospatial deficit in parkinsonian syndrome: a quantitative approach. J Neurol Donzuso G, Cilio F, Ferrante E, D'Agate C, Fazzina G, Cicero CE, Mostile G, Nicoletti A, Zappia M. PMID: 42804007 [PubMed - indexed for MEDLINE]
	Genetic architecture and molecular pathogenesis of Parkinson's disease: emerging mechanisms and therapeutic targets. Metab Brain Dis Yildirim S. PMID: 42803978 [PubMed - indexed for MEDLINE]
	Selective umami taste impairment in anosmic Parkinson's disease: associations with non-motor symptoms. Ideggyogy Sz Yavuz Z, Önder H, Eldek FA, Çomoglu SS. PMID: 42803097 [PubMed - indexed for MEDLINE]
	The patient-centric development of an inclusive multi-arm multi-stage trial for Parkinson's disease. Brain Commun Zeissler ML, Burnell M, Barber TR, Ben-Shlomo Y, Clarke CS, Collins S, Counsell C, Duffen J, Edwards MJ, Ellis-Doyle R, Gonzalez-Robles C, Hockey K, Jewell A, Lawton M, Mills G, Petty R, Salathiel D, Whipps S, Whone A, Gandhi S, Carroll CB, Foltynie T, Carpenter JR, Barker RA, EJS ACT-PD Consortium, EJS ACT-PD Consortium. PMID: 42802821 [PubMed]
	Mendelian randomization analysis reveals causal links between specific immune cell phenotypes and Parkinson's disease. Clinics (Sao Paulo) Su Y, Cai S, Xu Y, Xu Q, Wang Q, Chen X. PMID: 42801837 [PubMed - as supplied by publisher]
	Comparative study of Parkinson's disease phenotypes in homozygous and heterozygous LRRK2-G2019S mutation carriers. Acta Neurol Belg Abida Y, Sghaier I, Gharbi A, Souissi A, Elloumi M, Atrous A, Gargouri A, Kacem I, Gouider R. PMID: 42801451 [PubMed - as supplied by publisher]
	Ambroxol in Gaucher disease and GBA1-related Parkinson disease: an updated systematic review. Acta Neurol Belg Lipi, Jezela-Stanek A, Tylki-Szyma. PMID: 42801449 [PubMed - as supplied by publisher]
	White matter fractional anisotropy predicts Parkinson's disease medication changes with deep brain stimulation. Parkinsonism Relat Disord Schoen D, Shih P, West L, Deutsch S, Mehta J, Williams C, Wang S, Wang DD, Ostrem JL, Bledsoe IO, Morrison MA. PMID: 42800200 [PubMed - as supplied by publisher]
	Symptomatic Rescue or Disease Modification? A Critical Review of Levodopa and Phytochemical Interventions in Caenorhabditis elegans Models of Parkinson's Disease. Mol Neurobiol Akta, Berk . PMID: 42799932 [PubMed - indexed for MEDLINE]
	Systemic AR-C155858 During Fixed Treadmill Exercise in MPTP Mice: An Exploratory Study. Neurochem Res Kong J, Liu L, Zhao G, Gao Y, Yang Z, Zeng R, Tan M, Wang H, Liu Y, Chen W. PMID: 42799796 [PubMed - indexed for MEDLINE]
	Tremor relief after gamma knife thalamotomy for Parkinson's disease. Neurosurg Rev Reyes JS, Bouras A, Hadjipanayis CG, Lunsford LD, Niranjan A. PMID: 42799781 [PubMed - indexed for MEDLINE]
	Neuroinflammation and metabolic reprogramming in Parkinson's disease. Front Immunol Fu Y, Yu J, Xu L, Zhou T, Deng Q. PMID: 42798987 [PubMed - indexed for MEDLINE]
	MAFF as a potential novel protective factor against Parkinson's disease: evidence from Mendelian randomization and single-cell RNA sequencing. Front Aging Neurosci Li X, Wang Q, Min G, Yuan X, Tian Y. PMID: 42798606 [PubMed]

Articles 1 - 20 / 59012

Page 1 of 2951



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy